Related Experiment Videos
Optimal dose of a thiazide diuretic
The Medical Journal of Australia
|October 30, 1976
Summary
A lower dose of chlorthalidone (25 mg daily) effectively lowers blood pressure in essential hypertension with fewer side effects than a higher dose (100 mg). The 25 mg dose is preferred for hypertension management due to similar efficacy and reduced biochemical changes.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Nephrology
Background:
- Essential hypertension is a common condition requiring effective pharmacologic management.
- Diuretics, such as chlorthalidone, are frequently used to treat hypertension.
- Understanding dose-dependent effects is crucial for optimizing treatment and minimizing adverse events.
Purpose of the Study:
- To compare the antihypertensive efficacy of two different daily doses of chlorthalidone (25 mg vs. 100 mg).
- To evaluate the impact of these doses on extracellular volume, plasma renin activity, serum uric acid, and potassium levels.
- To determine the optimal dose of chlorthalidone for managing essential hypertension.
Main Methods:
- A comparative study involving patients with essential hypertension.
- Administration of chlorthalidone at 25 mg/day and 100 mg/day to different patient groups.
- Monitoring of blood pressure, extracellular volume, plasma renin activity, serum uric acid, and serum potassium levels.
Main Results:
- Both 25 mg and 100 mg of chlorthalidone demonstrated similar blood pressure-lowering effects.
- The 100 mg dose resulted in a greater reduction in extracellular volume and a more significant increase in plasma renin activity and serum uric acid.
- Hypokalemia was more frequent with the 100 mg dose, although neither dose led to total body potassium depletion.
Conclusions:
- The 25 mg daily dose of chlorthalidone provides substantial antihypertensive benefits.
- This lower dose is associated with fewer adverse biochemical changes compared to the 100 mg dose.
- 25 mg of chlorthalidone is recommended as the preferred dose for managing essential hypertension due to its favorable efficacy-to-safety profile.